Concordantly, MV contributed to a dose-dependent decrease of the gene expressions of pparg, srebp1, scd1, and fasn in contrast to those in NAFLD mice (Figure 2(f)). This evidence concerns the gene FASN and metabolic dysfunction-associated steatotic liver disease.